ResearcherUniversity of OsloNo recent work listed

Michael Leitges

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0003-4203-6995; OpenAlex author ID A5067987771. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2016: 1 paper

Papers 1

A bright future for protein kinase D1 as a drug target to prevent or treat pancreatic cancer. Last author DOI 10.1080/23723556.2015.1035477 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Peter Störz · 1 shared paper, 2016 · strength 0.10
- Paper A bright future for protein kinase D1 as a drug target to prevent or treat pancreatic cancer. DOI 10.1080/23723556.2015.1035477 ↗
Geou‐Yarh Liou · 1 shared paper, 2016 · strength 0.10
- Paper A bright future for protein kinase D1 as a drug target to prevent or treat pancreatic cancer. DOI 10.1080/23723556.2015.1035477 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.